Related references
Note: Only part of the references are listed.The p53 isoforms are differentially modified by Mdm2
Suzanne Camus et al.
CELL CYCLE (2012)
p53 protein expression in chronic lymphocytic leukemia
Ludger Sellmann et al.
LEUKEMIA & LYMPHOMA (2012)
Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia
N. Anensen et al.
ONCOGENE (2012)
Biological functions of p53 isoforms through evolution: lessons from animal and cellular models
V. Marcel et al.
CELL DEATH AND DIFFERENTIATION (2011)
Metabolic regulation by p53
Oliver D. K. Maddocks et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
Serum-Nutrient Starvation Induces Cell Death Mediated by Bax and Puma That Is Counteracted by p21 and Unmasked by Bcl-xL Inhibition
Frederique Braun et al.
PLOS ONE (2011)
p53 mutant breast cancer patients expressing p53 gamma have as good a prognosis as wild-type p53 breast cancer patients
Jean-Christophe Bourdon et al.
BREAST CANCER RESEARCH (2011)
Δ160p53 is a novel N-terminal p53 isoform encoded by Δ133p53 transcript
Virginie Marcel et al.
FEBS LETTERS (2010)
Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer
G. Hofstetter et al.
ONCOGENE (2010)
Identification of Novel p53 Pathway Activating Small-Molecule Compounds Reveals Unexpected Similarities with Known Therapeutic Agents
Karita Peltonen et al.
PLOS ONE (2010)
The Isoforms of the p53 Protein
Marie P. Khoury et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
p53 Research: The Past Thirty Years and the Next Thirty Years
David Lane et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Functional characterization of p53β and p53γ, two isoforms of the tumor suppressor p53
Vilma Graupner et al.
CELL CYCLE (2009)
p21 in cancer: intricate networks and multiple activities
Tarek Abbas et al.
NATURE REVIEWS CANCER (2009)
Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells
Line Wergeland et al.
MOLECULAR CANCER (2007)
Expression of p53 isoforms in squamous cell carcinoma of the head and neck
Linda Boldrup et al.
EUROPEAN JOURNAL OF CANCER (2007)
p53 isoforms can regulate p53 transcriptional activity
JC Bourdon et al.
GENES & DEVELOPMENT (2005)
Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2Rγnull mice engrafted with mobilized human hemopoietic stem cells
LD Shultz et al.
JOURNAL OF IMMUNOLOGY (2005)
Animal models of acute myelogenous leukaemia - development, application and future perspectives
E Mc Cormack et al.
LEUKEMIA (2005)
A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73
G Asher et al.
GENES & DEVELOPMENT (2005)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Optimization of methods and treatment conditions for studying effects of fatty acids on cell growth
KJ Tronstad et al.
LIPIDS (2001)
Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation
MS Rodriguez et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Electric cell-substrate impedance sensing (ECIS) as a noninvasive means to monitor the kinetics of cell spreading to artificial surfaces
J Wegener et al.
EXPERIMENTAL CELL RESEARCH (2000)
Share Paper
